Please provide your email address to receive an email when new articles are posted on . A novel combination that includes ceftriaxone, sulbactam and disodium EDTA, or CSE, was noninferior to meropenem ...

Bacterial blood infection, computer illustration. Researchers compared outcomes of continuous vs intermittent meropenem among critically ill patients with sepsis. Clinical outcomes among critically ...

Dublin, May 10, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Meropenem Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Sales revenue of Meropenem in the ...

Please provide your email address to receive an email when new articles are posted on . The FDA today approved the antibiotic meropenem for the treatment of abdominal infections in neonates and ...

Purpose: The stability of meropenem in i.v. solutions stored in polyvinyl chloride (PVC) bags and an elastomeric infusion device at concentrations commonly used in home care was studied. Methods: ...

Cefepime-taniborbactam, an investigational beta-lactam and beta-lactamase inhibitor combination, was superior to meropenem for the treatment of hospitalized patients with complicated urinary tract ...

Review the side-effects of Meropenem as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

The phase 3 CERTAIN-1 study compared the efficacy and safety of cefepime-taniborbactam to meropenem in 661 adults with cUTI. Positive results were announced from a phase 3 study evaluating ...

Discover comprehensive details about Meropenem and Vaborbactam, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

Meropenem has been approved by the Food and Drug Administration (FDA) for the treatment of abdominal infections in infants <3 months old. The approval was based on an open-label, multiple-dose study ...